DaVita Inc. is set to present seven clinical studies at ASN Kidney Week, underscoring the company's ongoing commitment to nephrology research and patient care innovation.
DaVita announced it will present seven studies at ASN Kidney Week, highlighting its clinical research commitment but with no immediate financial impact.
DaVita Inc. announced it will showcase seven clinical studies at the upcoming American Society of Nephrology (ASN) Kidney Week. The research focuses on advancements in middle molecule clearance, home dialysis modalities, and patient experience metrics.
DaVita will present seven studies covering middle molecule clearance, home dialysis, and patient experience.